Share LinkedIn Email Copy Link Berta Rodriguez-Hervas has joined the pharmaceutical company after stints at Stellantis, Nvidia and Tesla.Read more about this post on BioPharmaDive
EndPoints Pfizer ends work on Sangamo’s hemophilia gene therapy, crushing biotech’s hopesDecember 31, 2024
EndPoints Despite mixed data in Alzheimer’s agitation, Axsome will still seek FDA approvalDecember 30, 2024